Search

Author/Creator Jiang, Dongbo

1. In silico analyses and experimental validation of the MHC class-I restricted epitopes of Ebolavirus GP. (22nd February 2022)

Authors:
Liu, Yang; Sun, Baozeng; Wang, Jiawei; Sun, Hao; Lu, Zhenhua; Chen, Longyu; Lan, Mingfu; Xu, Jiahao; Pan, Jingyu; Shi, Jingqi; Sun, Yuanjie; Zhang, Xiyang; Wang, Jing; Jiang, Dongbo; Yang, Kun
Journal:
International immunology
Issue:
Volume 34:Number 6(2022)
Page Start:
313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. MiR‐145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on MYC. Issue 4 (22nd March 2023)

Authors:
Hu, Chenchen; Liu, Tianyue; Zhang, Wenxin; Sun, Yuanjie; Jiang, Dongbo; Zhang, Xiyang; Liu, Yang; Mao, Siyi; Xu, Yiming; Pan, Jingyu; Wang, Jing; Huang, Yinan; Yang, Shuya; Yang, Kun
Journal:
FASEB journal
Issue:
Volume 37:Issue 4(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. MiR‐362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway. (19th November 2020)

Authors:
Yang, Shuya; Sun, Yuanjie; Jiang, Dongbo; Wang, Jing; Dang, Erle; Li, Zichao; Zhou, Jiayi; Lu, Yuchen; Shi, Jingqi; Tao, Liang; Wang, Jun; Jin, Boquan; Zheng, Lianhe; Yang, Kun
Journal:
Cancer medicine
Issue:
Volume 10:Number 1(2021)
Page Start:
305
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗